dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Suspension
- RxCUI
- 1486140
- RxNorm name
- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Suspension
- Display name
- Dextromethorphan/guaiFENesin/Phenylephrine (Oral Liquid)
- Full name
- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Suspension
- Term type
- SCD
- Status
- Active
- Strength
- 10-200-5 mg/5ml
- Dose form
- Susp
- Route
- Oral Liquid
- Updated
- 2026-08-12 12:30:01
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 022014
- Active start
- 022014
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| dextromethorphan hydrobromide | 2 MG / 1 ML | dextromethorphan | dextromethorphan hydrobromide |
| guaifenesin | 40 MG / 1 ML | guaifenesin | guaifenesin |
| phenylephrine hydrochloride | 1 MG / 1 ML | phenylephrine | phenylephrine hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Suspension | 316969 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| dextromethorphan | 3289 |
| guaifenesin | 5032 |
| phenylephrine | 8163 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | dextromethorphan hydrobromide 2 MG/ML / guaiFENesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Suspension | NAMES |
| RxNorm Name | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Suspension | NAMES |
| RxNorm Synonym | dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG per 5 ML Oral Suspension | NAMES |
| RxNorm Synonym | dextromethorphan HBr 20 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 10 ML Oral Suspension | NAMES |
| TTY | SCD | ATTRIBUTES |
| RxCUI | 1486140 | CODES |
| MMSL_CODE | BD26456 | CODES |
UNII Substances#
No records found.
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d1da2b49-af3a-4b80-a62c-c9147dab3113 | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Suspension | SCD | 6 | AGC-BiocotronDSus 208 | 20241220 |
| d1da2b49-af3a-4b80-a62c-c9147dab3113 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | PSN | 6 | AGC-BiocotronDSus 208 | 20241220 |
| d1da2b49-af3a-4b80-a62c-c9147dab3113 | dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG per 5 ML Oral Suspension | SY | 6 | AGC-BiocotronDSus 208 | 20241220 |
| d1da2b49-af3a-4b80-a62c-c9147dab3113 | dextromethorphan HBr 20 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 10 ML Oral Suspension | SY | 6 | AGC-BiocotronDSus 208 | 20241220 |
| 632d4219-7c36-4ed1-a5d0-7d0021b778a9 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | PSN | 1 | G-BRONCO-D | 20150629 |
| 632d4219-7c36-4ed1-a5d0-7d0021b778a9 | dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG per 5 ML Oral Suspension | SY | 1 | G-BRONCO-D | 20150629 |
| 632d4219-7c36-4ed1-a5d0-7d0021b778a9 | dextromethorphan HBr 20 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 10 ML Oral Suspension | SY | 1 | G-BRONCO-D | 20150629 |
| 632d4219-7c36-4ed1-a5d0-7d0021b778a9 | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Suspension | SCD | 1 | G-BRONCO-D | 20150629 |
DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| d1da2b49-af3a-4b80-a62c-c9147dab3113 | AGC-BiocotronDSus 208 | Advanced Generic Corporation | 20241220 |
| 16c331ed-9d03-44d6-8345-efeb9e4993cc | Perrigo Tussin Drug Facts | L. Perrigo Company | 20201112 |
| 730ae179-352a-475f-bcff-b792c44bf2a9 | Drug Facts | EQUATE (Wal-Mart Stores, Inc.) | P & L Development, LLC | 20191212 |
| 79d22530-8bee-4437-878a-8086acc5b082 | Topco Associates LLC. Tussin CF Max Drug Facts | Topco Associates LLC | 20191203 |
| 2a00467a-1bde-48ff-9134-71838a8a69be | Drug Facts | Aurohealth LLC | 20191101 |
| 162a7d4f-8e3f-4fe3-9c08-30bb54032fae | Drug Facts | FAZ Marketing | 20191031 |
| 3c59bc72-2169-419c-a2dc-5346d7ff918f | Drug Facts | FAZ Marketing | 20191031 |
| 019d6575-f17d-468c-ae92-d5183c4cbea8 | Hy-Vee, Inc. Tussin DM Max Drug Facts | HyVee Inc | 20190719 |
| b0dca193-ec1f-4d4b-99b4-4435cf59db8c | Cardinal Health Tussin Drug Facts | Cardinal Health | 20161129 |
| 632d4219-7c36-4ed1-a5d0-7d0021b778a9 | G-BRONCO-D | MCLAREN MEDICAL INC | 20150629 |
| 55d9f06a-868f-43d1-8c28-398a91a8ff80 | National Council for Prescription Drug Programs | 20130303 | |
| 040cecd6-29dc-448e-affe-663d7fc37c2a | National Council for Prescription Drug Programs | 20130213 | |
| 19a5426e-8d67-4b61-94bd-4e14cbd83e24 | National Council for Prescription Drug Programs | 20130213 | |
| 34644143-fbba-4e90-ad11-328c5ddefd37 | National Council for Prescription Drug Programs | 20130213 | |
| 1deb2bc6-6a8e-415c-a3dd-6cfc3679f0a8 | National Council for Prescription Drug Programs | 20120724 | |
| bfd9b718-ad4e-478d-bb62-5229635e0373 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C01CA | Adrenergic and dopaminergic agents | ATC1-4 | phenylephrine | |
| ATC | R05CA | Expectorants | ATC1-4 | guaifenesin | |
| ATC | R05DA | Opium alkaloids and derivatives | ATC1-4 | dextromethorphan | |
| ATC | C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use | ATC1-4 | phenylephrine | |
| ATC | R01BA | Sympathomimetics | ATC1-4 | phenylephrine | |
| ATC | S01FB | Sympathomimetics excl. antiglaucoma preparations | ATC1-4 | phenylephrine | |
| ATC | S01GA | Sympathomimetics used as decongestants | ATC1-4 | phenylephrine | |
| ATC | R01AB | Sympathomimetics, combinations excl. corticosteroids | ATC1-4 | phenylephrine | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | phenylephrine | |
| FDASPL | N0000186105 | alpha-1 Adrenergic Agonist | EPC | has_epc | phenylephrine |
| FDASPL | N0000193956 | Expectorant | EPC | has_epc | guaifenesin |
| FDASPL | N0000182149 | Sigma-1 Agonist | EPC | has_epc | dextromethorphan |
| FDASPL | N0000181821 | Uncompetitive N-methyl-D-aspartate Receptor Antagonist | EPC | has_epc | dextromethorphan |
| FDASPL | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan |
| FDASPL | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan |
| MEDRT | D003915 | Dextromethorphan | CHEM | has_ingredient | dextromethorphan |
| MEDRT | D003915 | Dextromethorphan | CHEM | has_ingredient | dextromethorphan hydrobromide |
| MEDRT | D006140 | Guaifenesin | CHEM | has_ingredient | guaifenesin |
| MEDRT | D010656 | Phenylephrine | CHEM | has_ingredient | phenylephrine hydrochloride |
| MEDRT | D010656 | Phenylephrine | CHEM | has_ingredient | phenylephrine |
| MEDRT | D013447 | Sulfites | CHEM | ci_chemclass | phenylephrine |
| MEDRT | D013447 | Sulfites | CHEM | ci_chemclass | phenylephrine hydrochloride |
| MEDRT | D001991 | Bronchitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | guaifenesin |
| MEDRT | D003371 | Cough | DISEASE | may_prevent | dextromethorphan hydrobromide |
| MEDRT | D003371 | Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | D003371 | Cough | DISEASE | may_treat | dextromethorphan |
| MEDRT | D003371 | Cough | DISEASE | may_prevent | dextromethorphan |
| MEDRT | D003371 | Cough | DISEASE | may_treat | dextromethorphan hydrobromide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | phenylephrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dextromethorphan hydrobromide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | guaifenesin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dextromethorphan |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | phenylephrine |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | phenylephrine |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | phenylephrine |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | phenylephrine |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | phenylephrine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D007827 | Laryngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | phenylephrine hydrochloride |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | phenylephrine |
| MEDRT | D010612 | Pharyngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | phenylephrine |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | guaifenesin |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | phenylephrine |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | phenylephrine |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D013617 | Tachycardia, Supraventricular | DISEASE | may_treat | phenylephrine |
| MEDRT | D013617 | Tachycardia, Supraventricular | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | ci_with | phenylephrine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D014917 | Whooping Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | phenylephrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | phenylephrine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | dextromethorphan hydrobromide |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | dextromethorphan |
| MEDRT | N0000000109 | Serotonin Uptake Inhibitors | MOA | has_moa | dextromethorphan |
| MEDRT | N0000000109 | Serotonin Uptake Inhibitors | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan |
| MEDRT | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | phenylephrine |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | phenylephrine hydrochloride |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | dextromethorphan hydrobromide |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | dextromethorphan |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | phenylephrine hydrochloride |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | phenylephrine |
| MEDRT | N0000008867 | Decreased Respiratory Secretion Viscosity | PE | has_pe | guaifenesin |
| MEDRT | N0000009560 | Increased Respiratory Secretions | PE | has_pe | guaifenesin |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 2 MG/ML / 40 MG/ML / 1 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | SCD |
| CODES | MMSL_CODE | BD26456 |
| CODES | RxCUI | 1486140 |
| CODES | VUID | 4035142 |
| NAMES | Prescribable Synonym | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension |
| NAMES | RXNAV_STR | dextromethorphan hydrobromide 2 MG/ML / guaiFENesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Suspension |
| NAMES | RxNorm Name | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Suspension |
| NAMES | RxNorm Synonym | dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG per 5 ML Oral Suspension |
| NAMES | RxNorm Synonym | dextromethorphan HBr 20 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 10 ML Oral Suspension |
| NAMES | Tallman Synonym | dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 5 ML Oral Suspension |
| NAMES | Tallman Synonym | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG per 10 ML Oral Suspension |
| NAMES | Tallman Synonym | dextromethorphan hydrobromide 2 MG/ML / guaiFENesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Suspension |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |